These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31870725)

  • 21. An Update on Autoinflammatory Diseases: Inflammasomopathies.
    Harapas CR; Steiner A; Davidson S; Masters SL
    Curr Rheumatol Rep; 2018 May; 20(7):40. PubMed ID: 29846819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Disease-associated Mutant of NLRC4 Shows Enhanced Interaction with SUG1 Leading to Constitutive FADD-dependent Caspase-8 Activation and Cell Death.
    Raghawan AK; Sripada A; Gopinath G; Pushpanjali P; Kumar Y; Radha V; Swarup G
    J Biol Chem; 2017 Jan; 292(4):1218-1230. PubMed ID: 27974463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NLRC4 gets out of control.
    Khameneh HJ; Mortellaro A
    Nat Genet; 2014 Oct; 46(10):1048-9. PubMed ID: 25257084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical update on inflammasomopathies.
    Sönmez HE; Özen S
    Int Immunol; 2017 Nov; 29(9):393-400. PubMed ID: 28387826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation Syndrome.
    Barsalou J; Blincoe A; Fernandez I; Dal-Soglio D; Marchitto L; Selleri S; Haddad E; Benyoucef A; Touzot F
    Front Immunol; 2018; 9():2162. PubMed ID: 30319625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The autoinflammation-associated NLRC4
    Eeckhout E; Asaoka T; Van Gorp H; Demon D; Girard-Guyonvarc'h C; Andries V; Vereecke L; Gabay C; Lamkanfi M; van Loo G; Wullaert A
    Front Immunol; 2023; 14():1272639. PubMed ID: 38090573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NLRC4 biology in immunity and inflammation.
    Andrade WA; Zamboni DS
    J Leukoc Biol; 2020 Oct; 108(4):1117-1127. PubMed ID: 32531834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO).
    Johansson Å; Eriksson N; Becker RC; Storey RF; Himmelmann A; Hagström E; Varenhorst C; Axelsson T; Barratt BJ; James SK; Katus HA; Steg PG; Syvänen AC; Wallentin L; Siegbahn A;
    Circ Cardiovasc Genet; 2015 Jun; 8(3):498-506. PubMed ID: 25747584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoinflammation: NLRC4 mutation causes rare autoinflammatory disease.
    Bernard NJ
    Nat Rev Rheumatol; 2014 Nov; 10(11):635. PubMed ID: 25266450
    [No Abstract]   [Full Text] [Related]  

  • 30. Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.
    Jamilloux Y; Lefeuvre L; Magnotti F; Martin A; Benezech S; Allatif O; Penel-Page M; Hentgen V; Sève P; Gerfaud-Valentin M; Duquesne A; Desjonquères M; Laurent A; Rémy-Piccolo V; Cimaz R; Cantarini L; Bourdonnay E; Walzer T; Py BF; Belot A; Henry T
    Rheumatology (Oxford); 2018 Jan; 57(1):100-111. PubMed ID: 29040788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoinflammation with Infantile Enterocolitis Associated with Recurrent Perianal Abscesses.
    Siahanidou T; Nikaina E; Kontogiorgou C; Tzanoudaki M; Stefanaki K; Skiathitou AV; Petropoulou T; Kanariou M
    J Clin Immunol; 2019 Apr; 39(3):237-240. PubMed ID: 30864118
    [No Abstract]   [Full Text] [Related]  

  • 32. NLRC4, inflammation and colorectal cancer (Review).
    Tong G; Shen Y; Li H; Qian H; Tan Z
    Int J Oncol; 2024 Oct; 65(4):. PubMed ID: 39239759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of NLRC4 in children with septicaemia and mechanisms of NLRC4 in in vitro cytokine secretion.
    Zhu G; Chen J; Tian J; Ge L; Xing A; Tang G
    Mol Med Rep; 2016 Jul; 14(1):509-14. PubMed ID: 27175981
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Li Y; Sun C; Cui L; Wang Q
    Comput Math Methods Med; 2021; 2021():8581746. PubMed ID: 34925545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome.
    Rowczenio DM; Pathak S; Arostegui JI; Mensa-Vilaro A; Omoyinmi E; Brogan P; Lipsker D; Scambler T; Owen R; Trojer H; Baginska A; Gillmore JD; Wechalekar AD; Lane T; Williams R; Youngstein T; Hawkins PN; Savic S; Lachmann HJ
    Blood; 2018 Mar; 131(9):974-981. PubMed ID: 29284595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Identification of rare variants in exons of NLRC4 gene in patients with type 1 diabetes and their impact on gene function].
    Xu LL; Luo HR; Shi XJ; Pang HP; Li JQ; Wang YM; Luo SM; Lin J; Yu HB; Xiao Y; Li X; Huang G; Xie ZG; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(16):1216-1223. PubMed ID: 35462504
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular Characterization of the NLRC4 Expression in Relation to Interleukin-18 Levels.
    Zeller T; Haase T; Müller C; Riess H; Lau D; Zeller S; Krause J; Baumert J; Pless O; Dupuis J; Wild PS; Eleftheriadis M; Waldenberger M; Zeilinger S; Ziegler A; Peters A; Tiret L; Proust C; Marzi C; Munzel T; Strauch K; Prokisch H; Lackner KJ; Herder C; Thorand B; Benjamin EJ; Blankenberg S; Koenig W; Schnabel RB
    Circ Cardiovasc Genet; 2015 Oct; 8(5):717-26. PubMed ID: 26362438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NLRC4 GOF Mutations, a Challenging Diagnosis from Neonatal Age to Adulthood.
    Bardet J; Laverdure N; Fusaro M; Picard C; Garnier L; Viel S; Collardeau-Frachon S; Guillebon JM; Durieu I; Casari-Thery C; Mortamet G; Laurent A; Belot A
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythematous nodes, urticarial rash and arthralgias in a large pedigree with NLRC4-related autoinflammatory disease, expansion of the phenotype.
    Volker-Touw CM; de Koning HD; Giltay JC; de Kovel CG; van Kempen TS; Oberndorff KM; Boes ML; van Steensel MA; van Well GT; Blokx WA; Schalkwijk J; Simon A; Frenkel J; van Gijn ME
    Br J Dermatol; 2017 Jan; 176(1):244-248. PubMed ID: 27203668
    [No Abstract]   [Full Text] [Related]  

  • 40. Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition.
    Canna SW; Girard C; Malle L; de Jesus A; Romberg N; Kelsen J; Surrey LF; Russo P; Sleight A; Schiffrin E; Gabay C; Goldbach-Mansky R; Behrens EM
    J Allergy Clin Immunol; 2017 May; 139(5):1698-1701. PubMed ID: 27876626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.